358 related articles for article (PubMed ID: 35427726)
1. The therapeutic mechanism of PuRenDan for the treatment of diabetic nephropathy: Network pharmacology and experimental verification.
Niu H; Fan L; Zhao L; Yao R; He X; Lu B; Pang Z
J Ethnopharmacol; 2022 Jul; 293():115283. PubMed ID: 35427726
[TBL] [Abstract][Full Text] [Related]
2. Network pharmacology analysis combined with experimental validation to explore the therapeutic mechanism of Schisandra Chinensis Mixture on diabetic nephropathy.
Ma Y; Deng Y; Li N; Dong A; Li H; Chen S; Zhang S; Zhang M
J Ethnopharmacol; 2023 Feb; 302(Pt A):115768. PubMed ID: 36280016
[TBL] [Abstract][Full Text] [Related]
3. The Mechanism of Plantaginis Semen in the Treatment of Diabetic Nephropathy based on Network Pharmacology and Molecular Docking Technology.
He L; Shen K; He L; Chen Y; Tang Z
Endocr Metab Immune Disord Drug Targets; 2024; 24(3):363-379. PubMed ID: 37718520
[TBL] [Abstract][Full Text] [Related]
4. An integrated network pharmacology and transcriptomic method to explore the mechanism of the total Rhizoma Coptidis alkaloids in improving diabetic nephropathy.
Xiao Y; Liu Y; Lai Z; Huang J; Li C; Zhang Y; Gong X; Deng J; Ye X; Li X
J Ethnopharmacol; 2021 Apr; 270():113806. PubMed ID: 33444721
[TBL] [Abstract][Full Text] [Related]
5. Exploring the mechanisms underlying the therapeutic effect of Salvia miltiorrhiza in diabetic nephropathy using network pharmacology and molecular docking.
Zhang L; Han L; Wang X; Wei Y; Zheng J; Zhao L; Tong X
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 33634308
[TBL] [Abstract][Full Text] [Related]
6. Network pharmacology-based investigation of potential targets of astragalus membranaceous-angelica sinensis compound acting on diabetic nephropathy.
Dong Y; Zhao Q; Wang Y
Sci Rep; 2021 Sep; 11(1):19496. PubMed ID: 34593896
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of Astragalus mongholicus Bunge ameliorating cerebral ischemia-reperfusion injury: Based on network pharmacology analysis and experimental verification.
Li R; Lou Q; Ji T; Li Y; Yang H; Ma Z; Zhu Y; Qian C; Yang W; Wang Y; Luo S
J Ethnopharmacol; 2024 Jul; 329():118157. PubMed ID: 38588987
[TBL] [Abstract][Full Text] [Related]
8. Network Pharmacology Analysis of ZiShenWan for Diabetic Nephropathy and Experimental Verification of Its Anti-Inflammatory Mechanism.
Guo X; Wu Y; Zhang C; Wu L; Qin L; Liu T
Drug Des Devel Ther; 2021; 15():1577-1594. PubMed ID: 33883881
[TBL] [Abstract][Full Text] [Related]
9. Network pharmacology and molecular docking technology-based predictive study of the active ingredients and potential targets of rhubarb for the treatment of diabetic nephropathy.
Fu S; Zhou Y; Hu C; Xu Z; Hou J
BMC Complement Med Ther; 2022 Aug; 22(1):210. PubMed ID: 35932042
[TBL] [Abstract][Full Text] [Related]
10. Exploring the mechanism of hirudin in the treatment of diabetic kidney disease using network pharmacology combined with molecular docking verification.
Xinxin P; Qing Z; Zining P; Yage Z; Xiujie S; Jiarui H
J Tradit Chin Med; 2022 Aug; 42(4):586-594. PubMed ID: 35848975
[TBL] [Abstract][Full Text] [Related]
11. Uncovering the Key miRNAs and Targets of the Liuwei Dihuang Pill in Diabetic Nephropathy-Related Osteoporosis based on Weighted Gene Co-Expression Network and Network Pharmacology Analysis.
Liu MM; Lv NN; Geng R; Hua Z; Ma Y; Huang GC; Cheng J; Xu HY
Endocr Metab Immune Disord Drug Targets; 2022; 22(3):274-289. PubMed ID: 33588742
[TBL] [Abstract][Full Text] [Related]
12. Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway.
Mao J; Lu Q; Gao F; Liu H; Tan J
J Vis Exp; 2024 May; (207):. PubMed ID: 38801274
[TBL] [Abstract][Full Text] [Related]
13. Exploring the mechanism of Dahuang-Tusizi drug pair in the treatment of diabetes nephropathy based on network pharmacology and immune infiltration analysis.
Liu W; Yuan L; Che M; Hou S; Meng F; Xu D; Nan Y
Medicine (Baltimore); 2023 Nov; 102(47):e36196. PubMed ID: 38013385
[TBL] [Abstract][Full Text] [Related]
14. Network pharmacology-based identification of miRNA expression of Astragalus membranaceus in the treatment of diabetic nephropathy.
Dai Y; Guo M; Jiang L; Gao J
Medicine (Baltimore); 2022 Feb; 101(5):e28747. PubMed ID: 35119030
[TBL] [Abstract][Full Text] [Related]
15. Prediction of the Potential Mechanism of Triptolide in Improving Diabetic Nephropathy by Utilizing A Network Pharmacology and Molecular Docking Approach.
An X; Fan D; Yin Z; Zhang J; Zhou Y; Tian R; Yan M
Front Biosci (Landmark Ed); 2022 Mar; 27(3):94. PubMed ID: 35345326
[TBL] [Abstract][Full Text] [Related]
16. Revealing active components, action targets and molecular mechanism of Gandi capsule for treating diabetic nephropathy based on network pharmacology strategy.
Zhang Q; Ye Q; Huang X; Xu A; Liu Y; Qi J; Zhang H; Zhang J
BMC Complement Med Ther; 2020 Nov; 20(1):362. PubMed ID: 33228635
[TBL] [Abstract][Full Text] [Related]
17. Network pharmacology combined with Mendelian randomization analysis to identify the key targets of renin-angiotensin-aldosterone system inhibitors in the treatment of diabetic nephropathy.
Zhou D; Zhou T; Tang S; Li Q; Li W; Gan G; Li M; Chen Q
Front Endocrinol (Lausanne); 2024; 15():1354950. PubMed ID: 38332893
[TBL] [Abstract][Full Text] [Related]
18. Study on the Potential Mechanism of Tonifying Kidney and Removing Dampness Formula in the Treatment of Postmenopausal Dyslipidemia Based on Network Pharmacology, Molecular Docking and Experimental Evidence.
Li X; Chen H; Yang H; Liu J; Li Y; Dang Y; Wang J; Wang L; Li J; Nie G
Front Endocrinol (Lausanne); 2022; 13():918469. PubMed ID: 35872979
[TBL] [Abstract][Full Text] [Related]
19. The therapeutic mechanism of Yuye decoction on type 2 diabetes mellitus based on network pharmacology and experimental verification.
Guo F; Yao L; Zhang W; Chen P; Hao R; Huang X; Jiang J; Wu S
J Ethnopharmacol; 2023 May; 308():116222. PubMed ID: 36828194
[TBL] [Abstract][Full Text] [Related]
20. Deciphering the pharmacological mechanisms of Shenlingbaizhu formula in antibiotic-associated diarrhea treatment: Network pharmacological analysis and experimental validation.
Chen Y; Meng X; Zheng H; Gu Y; Zhu W; Wang S; Lin J; Li T; Liao M; Li Y; Guo S; Ding X
J Ethnopharmacol; 2024 Jul; 329():118129. PubMed ID: 38582151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
